The decisions behind scientific progress
From BioSpace · · 10 min
This plays from the publisher's own server. We do not host a copy.
Description
In this episode of Denatured, sponsored by Cytiva, Jennifer Smith-Parker speaks to Nicolas Pivet, VP & GM, Manufacturing & Digital Solutions at Cytiva. In this episode, we discuss how biopharma has long invested in more data and visibility, yet many programs still face delays and scale-up surprises. The real challenge isn’t information overload—it’s building confidence in the decisions that steer scientific progress from development through commercialization.
This episode is presented in partnership with Cytiva (https://www.cytivalifesciences.com/en/us).
Host
Jennifer Smith-Parker (https://www.linkedin.com/in/jennifersmithparker/), Director of Insights, BioSpace
Guest
Nicolas Pivet, (https://www.linkedin.com/in/nicolas-pivet-a30b891b/) VP & GM, Manufacturing & Digital Solutions, Cytiva
Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations